Background Many employers and health plans have adopted incentive-based formularies in
an attempt to control prescription-drug costs. Methods We used claims data to compare the …

Materials and methods. Longitudinal logistic regression analyses of pharmacy claims from
1998 and 1999 comparing concurrent groups that were or were not exposed to tiered …

Many US employers have recently adopted less generous prescription drug benefits. In
addition, in 2006 the US began to offer prescription drug insurance to approximately 42 …

ContextWith drug spending rising rapidly for working-aged adults, many employers and
health insurance providers have changed benefits packages to encourage use of fewer or …

This study estimates the impact of patient financial incentives on the use and cost of
prescription drugs in the context of differing physician payment mechanisms. A large data …

Increasing utilization of available drugs, coupled with the sustained development and
marketing of innovative products, is largely responsible for double-digit inflation in this …

A large value-based insurance design program offered by Blue Cross Blue Shield of North
Carolina eliminated generic medication copayments and reduced copayments for brand …

ContextMany health plans have instituted more cost sharing to discourage use of more
expensive pharmaceuticals and to reduce drug spending. ObjectiveTo determine how …

Objective: To determine whether a pharmacy benefit that varies copayments for cholesterol-
lowering (CL) therapy according to expected therapeutic benefit would improve compliance …

ContextThe majority of Medicare drug benefits in managed care (Medicare+ Choice) have
annual dollar limits or caps and many beneficiaries face temporary but potentially significant …